A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy
PHASE1
To assess the efficacy and safety of TQB2450 in combination with anlotinib ...
Status
Unknown
Location
Cancer Hospital Affiliated to Shandong First Medical University
TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis
PHASE1
In this study, single cell transcriptome sequencing will be performed on th...
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
PHASE3
A clinical study to evaluate the efficacy and safety of TQB2450 injection c...
A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).
PHASE3
This is Phase 3, randomized, open-label, parallel controlled study designed...
Status
Unknown
Location
Chinese Academy of Medical Sciences Cancer Hospital
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
PHASE2
This clinical study plans to enroll 69 endometrial cancer patients and 5-10...
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
PHASE3
A clinical study to evaluate the efficacy and safety of TQB2450 injection c...